Medical Advocates
HIV Infection/Disease
  Brain Disorders
General Reports  
 Diagnostics      
 Brain Abscesses    
Brain Atrophy  
Brain Lesions  
 Cerebral Histoplasmosis
Cerebral Lymphocytosis 
 Cerebral Toxoplasmosis   
Cerebral Vascular Disease
 Cognitive Impairment
 Cryptococcal Meningitis 
 		 Encephalopathy               
Encephalitis
Leukoencephalopathy
Memory Disorders
Movement Disorders  
Oncology
Seizures/Epilepsy
HIV/Psychiatric: General
Perception Disorders
Dementia
Stroke
 




 
CNS Main Page Main New/Newsworthy  Home Page

Last Update: May 15, 2012
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       
           Journal Papers, Abstracts, and Commentaries
 
 
Impact of HIV and aging on neuropsychological function.
 Wendelken LA, Valcour V.
J Neurovirol. 2012 Apr 14
 Abstract

Regional Brain Structural Dysmorphology in Human Immunodeficiency Virus Infection:
Effects of Acquired Immune Deficiency Syndrome, Alcoholism, and Age.
 Pfefferbaum A, Rosenbloom MJ, Sassoon SA, et al
Biol Psychiatry. 2012 Mar 26. |
 Abstract

FULL-TEXT ARTICLE
 Blood-Brain Barrier Abnormalities Caused by HIV-1 gp120: Mechanistic and Therapeutic Implications.
 Louboutin JP, Strayer DS.
 ScientificWorldJournal. 2012;2012:482575.
Paper

Prefrontal Dopaminergic and Enkephalinergic Synaptic Accommodation in HIV-associated Neurocognitive Disorders
 and Encephalitis.
 Gelman BB, Lisinicchia JG, Chen T,  et al
J Neuroimmune Pharmacol. 2012 Mar 6.
 Abstract

Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals.
Thompson KA, Cherry CL, Bell JE, McLean CA.
 Am J Pathol. 2011 Aug 23.
Abstract

Neurocognitive Impact of Antiretroviral Treatment: Thinking Long-Term.
 McPhail ME, Robertson KR.
Curr HIV/AIDS Rep. 2011 Aug 12
 Abstract

Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/
HIV-Associated Dementia.
Purohit V, Rapaka R, Shurtleff D.
 Mol Neurobiol. 2011 Jul 1.
Abstract

Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL, Archibald SL, Fennema-Notestine C,  et al
J Neurovirol. 2011 May 5.
Abstract

Alterations in brain metabolism during the first year of HIV infection.
Lentz MR, Kim WK, Kim H, et alJ Neurovirol. 2011 Apr 15.
Abstract

Factors affecting brain structure in men with HIV disease in the post-HAART era.
Becker JT, Maruca V, Kingsley LA, et al
Neuroradiology. 2011 Mar 22.
 Abstract

Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected
individuals.
Lin K, Taylor MJ, Heaton R,  et al
J Clin Exp Neuropsychol. 2011 Jan 10:1-9.
Abstract

Eradication of HIV from the brain: reasons for pause.
Nath A, Clements JE.
AIDS. 2010 Dec 14.
Abstract

Neurocognitive Consequences of HIV Infection in Older Adults: An Evaluation of the
"Cortical" Hypothesis.
Scott JC, Woods SP, Carey CL,  et al
AIDS Behav. 2010 Sep 24
 Abstract

Could differential virological characteristics account for ongoing viral replication
and insidious damage of the brain during HIV 1 infection of the central nervous
system?
Vissers M, Stelma FF, Koopmans PP.
J Clin Virol. 2010 Sep 10.
 Abstract

Subcortical Profile of Memory Compromise Among HIV-1-Infected Individuals.
Schiller A, Foley J, Burns W, et al 
Int J Neurosci. 2009;119(10):1779-1803
 Abstract

Brain: non-infective and non-neoplastic manifestations of HIV.
Saravanan M, Turnbull IW.  
Br J Radiol. 2009 Nov;82(983):956-65.
 Abstract

Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different
regions of postmortem human brains.
Kumar AM, Fernandez J, Singer EJ, et al
J Neurovirol. 2009 Jun 3:1-18
 Abstract

White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.
Gongvatana A, Schweinsburg BC, Taylor MJ,  et al 
J Neurovirol. 2009 Mar 22:1-9
 Abstract
 
White matter changes in HIV-1 infected brains: A combined gross anatomical and ultrastructural
morphometric investigation of the corpus callosum.
Wohlschlaeger J, Wenger E, Mehraein P, Weis S. 
Clin Neurol Neurosurg. 2009 Jan 28
 Abstract
 
Neurocognitive disturbances in HIV.
 Grant I.   
 Int Rev Psychiatry. 2008 Feb;20(1):33-47.
 Abstract
 
Co-factors in HIV neurobehavioural disturbances: Substance abuse, hepatitis C and aging.
 Gonzalez R, Cherner M.
 Int Rev Psychiatry. 2008 Feb;20(1):49-60.
 Abstract
 
Antiretroviral Treatment is Associated with Increased Attentional Load-Dependent Brain
Activation in HIV Patients.
Chang L, Yakupov R, Nakama H,, et al
J Neuroimmune Pharmacol. 2007 Oct 13
 Abstract

Biomarkers for neuroAIDS: the widening scope of metabolomics.
 Pendyala G, Want EJ, Webb W, et al  
 J Neuroimmune Pharmacol. 2007 Mar;2(1):72-80.
Abstract
 
The effects of illicit drugs on the HIV infected brain.
Anthony IC, Arango JC, Stephens B,et al 
Front Biosci. 2008 Jan 1;13:1294-307.
 Abstract
 
Memory performance in HIV/AIDS--a prospective case control study.
Odiase FE, Ogunrin OA, Ogunniyi AA.
Can J Neurol Sci. 2007 May;34(2):154-9.
 Abstract
 
Coma as a presenting symptom of primary HIV infection.
Umgelter A, Huber W, Schmid RM, Reindl W.
Sex Transm Infect. 2007 Apr;83(2):85-6.
 Abstract
 
Cerebral Aneurysmal Arteriopathy Associated with HIV Infection in an Adult.
Ake JA, Erickson JC, Lowry KJ. et al, et al    
Clin Infect Dis. 2006 Sep 1;43(5):e46-e50
 Abstract
 
The Blood-Brain Barrier in NeuroAIDS.
 Banks WA, Ercal N, Price TO.
 Curr HIV Res. 2006 Jul;4(3):259-66.
Abstract
 
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
Cysique LA, Maruff P, Brew BJ.
Neurology. 2006 May 9;66(9):1447-50.
 Abstract
 
Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use
illicit drugs.
Bell JE, Arango JC, Anthony IC.
J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91.
Abstract
 
Diffusion Alterations in Corpus Callosum of Patients with HIV.
Wu Y, Storey P, Cohen BA, Epstein LG, et al  
AJNR Am J Neuroradiol. 2006  Mar;27(3):656-60.
 Abstract
 
HIV disorders of the brain: pathology and pathogenesis.
Del Valle L, Pina-Oviedo S.
Front Biosci. 2006 Jan 1;11:718-32.
 Abstract
 
ASPD Blunts the Effects of HIV and Antiretroviral Treatment on Event-Related Brain Potentials.
Bauer LO, Shanley JD.
 Neuropsychobiology. 2005 Nov 24;53(1):17-25
Abstract
 
HIV disorders of the brain; pathology and pathogenesis.
Del Valle L, Pina-Oviedo S. et al
 Front Biosci. 2006 Jan 1;11:718-32.
 Abstract
 
The blood brain barrier in HIV infection.
Berger JR, Avison M.
Front Biosci. 2004 Sep 1;9:141-6.
 Abstract

Independent Evolution of Human Immunodeficiency Virus (HIV) Drug Resistance
Mutations in Diverse Areas of the Brain in HIV-Infected Patients, with and without
Dementia, on Antiretroviral Treatment.
Smit TK, Brew BJ, Tourtellotte W, et al.
 J Virol. 2004 Sep;78(18):10133-48
 Abstract
 
Cardio- and cerebrovascular events in HIV-infected persons.
The Writing Committee 
AIDS. 2004 Sep 3;18(13):1811-1817.
 Abstract

Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration
induced by HAART.
Miller RF, Isaacson PG, Hall-Craggs M ,et al.  
Acta Neuropathol (Berl). 2004 Apr 14
 Abstract
 
          Conference Reports, Abstracts, and Posters
 
 
POSTER
 Role of Central Obesity, Diabetes, and Metabolic Variables in HIV-associated Neurocognitive Disorder
A McCutchan J Marquie-Beck, C FitzSimons, et al
(19 CROI)
PDF Poster     Abstract

POSTER
 Markers of Cardiovascular Risk and Evolution of Neurocognitive Performance in HIV-1+ Patients:
A Longitudinal Study
M Colafigli, P Grima, N Ciccarelli, et al
(19 CROI)
PDF Poster     Abstract  

New Evidence for Cardiovascular-related Brain Injury in Middle-aged HIV+ Individuals: A 1-H MRS Study
 L Cysique, D Moore, K Moffat, et al
 (19 CROI)
 Abstract

HIV and Aging Cause Independent Decreases in Resting State Functional Connectivity
 J Thomas, M Brier, A Snyder, B Ances
 (19 CROI)
 Abstract

Older Subjects with HIV Infection Have Increased Memory Impairment Compared to Younger Subjects
IL Tan, B Smith, E Hammond, et al
 (19 CROI)
 Abstract

Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures
 B Ances, M Ortega, F Vaida
 (19 CROI)
 Abstract

Increased Th1 Cytokines and Blood–Brain Barrier Dysfunction in HIV+ Patients with Neurosyphilis
 E Ho, L Tantalo, S Sahi,  et al
 (19 CROI)
 Abstract

Clinical Factors and Plasma Cytokine Markers Are Related to Brain Volumes in HIV+ Individuals
 A Gongvatana, S Correia, K Devlin, et al
 (19 CROI)
 Abstract
 

POSTER
 Neuropsychological Performance Is Better in HIV-infected Subjects Treated with
Neuroactive HAART
 F Starace, M de Stefano, A D’Abrosca, et al 
(17th CROI)
 PDF Poster    Abstract

POSTER
Impact of ApoE and Cerebrovascular Risk Factors on Brain Structure and Cognition
 in HIV in the HAART Era
 Nakamoto, N Jahanshad, K Kallianpur, et al
(17th CROI)
 PDF Poster    Abstract

POSTER
 HAART-experienced Subjects with HIV-associated Neurocognitive Disorders Have
Longitudinally Persistent Elevated HIV DNA Levels in CD14+CD16+ Monocytes
B Shiramizu, A Marshall, M Agsalda, et al 
(17tyhj CROI)
 PDF Poster    Abstract
Diagnostics
 
           Journal Papers, Abstracts, and Commentaries
 
 
Screening for cognitive impairment in human immunodeficiency virus.
 Valcour V, Paul R, Chiao S,  et al
Clin Infect Dis. 2011 Oct;53(8):836-42.
 Abstract

Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive
impairment and dementia.
Foley JM, Wright MJ, Gooding AL, Ettenhofer M, et al
Int Psychogeriatr. 2010 Nov 19:1-9.
 Abstract

Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance
imaging to cognitive function among nondemented individuals infected with HIV.
Paul RH, Ernst T, Brickman AM, et al
 J Int Neuropsychol Soc. 2008 Sep;14(5):725-33.
 Abstract
 
Neuroimaging in the Brain in HIV-1-Infected Patients.
Thurnher MM, Donovan Post MJ.
Neuroimaging Clin N Am. 2008 Feb;18(1):93-117.
 Abstract
 
Magnetic Resonance Imaging Findings of the Brain in Adult HIV and AIDS Patients.
Kloska SP, Husstedt IW, Schlegel PM, et al 
Rofo. 2007 Nov 16;
Abstract
 
Utility of brain biopsy in patients with acquired immunodeficiency syndrome before and after
introduction of highly active antiretroviral therapy.
Rosenow JM, Hirschfeld A.  
Neurosurgery. 2007 Jul;61(1):130-40;
Abstract
 
Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients.
Yaldizli O, Kastrup O, Obermann M, et al 
Neurol. 2006 Sep 21
 Abstract
 
3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS.
Thompson PM, Dutton RA, Hayashi KM, et al 
Neuroimage. 2006 Jan 18;
Abstract

The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex
using a new computerised cognitive test battery.
Cysique LA, Maruff P, Darby D, Brew BJ.  
Arch Clin Neuropsychol. 2005 Dec 9;
Abstract
Brain Abscesses
 

           Journal Papers, Abstracts, and Commentaries

 
Propionibacterium acnes brain abscess in a patient with HIV-1 infection.
 Lyons JL, Scripko PD, Mukerji SS,  et al
J Neurovirol. 2012 Mar 9..
 Abstract

Brain abscess: management and outcome analysis of a computed tomography era
experience with 973 patients.
Nathoo N, Nadvi SS, Narotam PK, van Dellen JR.
World Neurosurg. 2011 May-Jun;75(5-6):716-26.
 Abstract

Brain abscess due to viridans streptococci in a severely immunosuppressed HIV-infected
patient.
Vidal JE, Tuon FF.
Int J STD AIDS. 2009 Sep;20(9):654-6.
 Abstract

Brain abscess: clinical experience and analysis of prognostic factors.
Xiao F, Tseng MY, Teng LJ, Tseng HM, Tsai JC. 
Surg Neurol. 2005 May;63(5):442-9.
 Abstract
 
Mesencephalic cryptococcal abscesses presenting with parkinsonism as an initial
manifestation of AIDS.
Bouffard JP, Mena H, Ripple M, Troncoso J.
Mov Disord. 2003 Nov;18(11):1354-7.
 Abstract

Multiple brain abscesses caused by Fusobacterium nucleatum treated conservatively.
Heckmann JG, Lang CJ, Hartl H, Tomandl B.
Can J Neurol Sci. 2003 Aug;30(3):266-8.
Abstract
Brain Atrophy
           Journal Papers, Abstracts, and Commentaries
 
  Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection.
Ragin AB, Wu Y, Ochs R,  et al
J Neurovirol. 2011 Feb 8.
 Abstract

Subcortical brain atrophy persists even in HAART-regulated HIV disease.
Becker JT, Sanders J, Madsen SK,  et al;
Brain Imaging Behav. 2011 Jan 25.
 Abstract

Early brain atrophy in HIV infection: a radiological-stereological study.
Korbo L, Praestholm J, Skot J.
Neuroradiology 2002 Apr;44(4):308-313
 Abstract
Brain Lesions
       

     Journal Papers, Abstracts, and Commentaries

 
Frequent hemorrhagic lesions in cerebral toxoplasmosis in AIDS patients.
Bhagavati S, Choi J.
 J Neuroimaging. 2009 Apr;19(2):169-73.
 Abstract

Seizures in HIV-seropositive individuals: NIMHANS experience and review.
 Satishchandra P, Sinha S.
Epilepsia. 2008 Aug;49 Suppl
Abstract
 
An algorithmic approach to intracranial mass lesions in HIV/AIDS.
Smego RA Jr, Orlovic D, Wadula J.
Int J STD AIDS. 2006 Apr;17(4):271-6.
 Abstract

Management of HIV-associated focal brain lesions in developing countries.
Modi M, Mochan A, Modi G.et al 
QJM. 2004 Jul;97(7):413-421.
 Abstract
 
          Conference Reports, Abstracts, and Posters
 
  The influence of HAART on HIV-associated primary cerebral lymphoma
Goode C., Stebbing J., Mazhar D
(XVI  International AIDS Conference
Abstract
Cerebral Vascular Disease
 

           Journal Papers, Abstracts, and Commentaries

 
Cerebrovascular Diseases in HIV-infected Patients.
Monsuez JJ, Goujon C, Wyplosz B, et al
Curr HIV Res. 2009 Sep 1
 Abstract

Multiple Symptomatic Cerebral Arteriovenous Malformations in a Patient with HIV.
Alomari AI, Jiarakongmun P, Dejthevaporn C, Pongpech S.
AJNR Am J Neuroradiol. 2009 Feb 26
 Abstract
Cognitive Function/Impairment
       
           Journal Papers, Abstracts, and Commentaries
 
 
Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus
and Intrathecal Immune Activation.
 Airoldi M, Bandera A, Trabattoni D, et al 
Clin Dev Immunol. 2012;2012:467154.
Abstract

A pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in
HIV disease.
Becker JT, Dew MA, Aizenstein HJ, et al
Disabil Rehabil. 2012 Mar 30
Abstract
HIV-associated Neurocognitive Disorders: A Historical Review.
 Cecilia RE, Ovidiu R, Mihaela S, Dana CR
Neurologist. 2012 Mar;18(2):64-7.
 Abstract

Intra-individual Neurocognitive Variability Confers Risk of Dependence in Activities of Daily
Living among HIV-Seropositive Individuals without HIV-Associated Neurocognitive Disorders.
 Morgan EE, Woods SP, Grant I; and The HNRP Group.
 Arch Clin Neuropsychol. 2012 Feb 15.
 Abstract

Diagnosing Symptomatic HIV-Associated Neurocognitive Disorders: Self-Report Versus
Performance-Based Assessment of Everyday Functioning.
 Blackstone K, Moore DJ, Heaton RK, et al
J Int Neuropsychol Soc. 2011 Nov 24
 Abstract

The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future.
Cysique LA, Bain MP, Brew BJ, Murray JM.
Sex Health. 2011 Nov;8(4):541-50.
 Abstract

Effects of highly active antiretroviral therapy on cognitive functions in severely immune-compromised
HIV-seropositive patients.
 Obiabo YO, Ogunrin OA, Ogun AS.
  J Neurol Sci. 2011 Oct 11.
 Abstract

Neurocognitive Impact of Substance Use in HIV Infection.
 Byrd DA, Fellows RP, Morgello S, et al
J Acquir Immune Defic Syndr. 2011 Jun 30.
 Abstract

HIV-1 infection and alcohol abuse: Neurocognitive impairment, mechanisms of neurodegeneration
and therapeutic interventions.
 Persidsky Y, Ho W, Ramirez SH,  et al
Brain Behav Immun. 2011 Jun;25 Suppl 1:S61-70.|
 Abstract

Neurocognitive impairment and neuroCART.
Wright E.
Curr Opin HIV AIDS. 2011 May 5
 Abstract

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era
of highly active antiretroviral treatment.
Harezlak J, Buchthal S, Taylor M, et al
AIDS. 2011 Feb 3
 Abstract

Neurocognitive functioning in acute or early HIV infection.
Moore DJ, Letendre SL, Morris S,  et al
J Neurovirol. 2010 Dec 15.
Abstract

HIV-1 infection and cognitive impairment in the cART-era: a review.
Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P.
AIDS. 2010 Dec 14
 Abstract

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy:
CHARTER Study.
Heaton RK, Clifford DB, Franklin DR Jr, et al
Neurology. 2010 Dec 7;75(23):2087-2096
 Abstract

Human immunodeficiency virus-associated neurocognitive disorders:
Mind the gap.
McArthur JC, Steiner J, Sacktor N, Nath A.
Ann Neurol. 2010 Jun;67(6):699-714.
 Abstract

Implications of positive and negative neuroplasticity on cognition in HIV.
Vance DE. 
Med Sci Monit. 2010 Apr 1;16(4):HY3-5
 Abstract

Does highly active antiretroviral therapy improve neurocognitive function?
A systematic review.
Joska JA, Gouse H, Paul RH,  et al
J Neurovirol. 2010 Mar 29
 Abstract

Neurocognitive effects of treatment interruption in stable HIV-positive patients
in an observational cohort.
Robertson KR, Su Z, Margolis DM, et al 
Neurology. 2010 Mar 17.
Abstract

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
Simioni S, Cavassini M, Annoni JM, et al  
AIDS. 2009 Dec 7
 Abstract

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking
systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive
disorders.
Tozzi V, Balestra P, Salvatori MF, et al
 J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63
 Abstract

HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
Ances BM, Clifford DB.
 Curr Neurol Neurosci Rep. 2008 Nov;8(6):455-61.
 Abstract
 
Effects of antiretroviral therapy on cognitive impairment.
 Liner Ii KJ, Hall CD, Robertson KR.  
Curr HIV/AIDS Rep. 2008 May;5(2):64-71
 Abstract

Voltage-gated Potassium Channels in Human Immunodeficiency Virus Type-1 (HIV-1)-associated
Neurocognitive Disorders.
Keblesh J, Hu D, Xiong H.
J Neuroimmune Pharmacol. 2008 May 6
Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment:
Open-Label Reportof ACTG 5090.
Evans SR, Yeh TM, Sacktor N, et al 
HIV Clin Trials. 2007 Nov-Dec;8(6):437-46.
 Abstract
 
FULL TEXT PDF ARTICLE
 Pattern of neuropsychological performance among HIV positive patients in Uganda.
Robertson KR, Nakasujja N, Wong M, et al 
BMC Neurol. 2007 Apr 5;7(1):8
 Paper
 
Cognitive slowing in asymptomatic individuals who are seropositive for human
immunodeficiency virus type 1.
Amador F, Mayor-Rios J, Del Castillo-Martin N.
Rev Neurol. 2006 Feb 1-15;42(3):132-6.
 Abstract
 
Prevalence and risk factors for human immunodeficiency virus-associated
neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort.
Tozzi V, Balestra P, Lorenzini P, et al    
J Neurovirol. 2005 Jul;11(3):265-73.
 Abstract
 
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.
Letendre SL, McCutchan JA, Childers ME, et al
Ann Neurol. 2004 Sep;56(3):416-423.
Abstract
 
ERPs differ from neurometric tests in assessing HIV-associated cognitive deficit.
Tartar JL, Sheehan CM, Nash AJ,et al 
Neuroreport. 2004 Jul 19;15(10):1675-1678.
 Abstract
 
Highly active antiretroviral therapy improves neurocognitive functioning.
Robertson KR, Robertson WT, Ford S, et al
J Acquir Immune Defic Syndr. 2004 Apr 15;36(1):562-6.
Abstract

The Effect of Previous Alcohol Abuse on Cognitive Function in HIV Infection.
Green JE, Saveanu RV, Bornstein RA. 
Am J Psychiatry. 2004 Feb;161(2):249-54.
Abstract

Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early
After HIV Seroconversion.
Marcotte TD, Deutsch R, McCutchan JA, et al.
 Abstract
 
Neurocognitive Function in HIV-Infected Patients With Low Weight and Weight Loss.
Dolan S, Montagno A, Wilkie S, et al >
J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):155-64.
Abstract

The role of cognitive impairment in desire for hastened death: a study of patients with
advanced AIDS.
Pessin H, Rosenfeld B, Burton L, Breitbart W .
Gen Hosp Psychiatry 2003 May-Jun;25(3):194-9
 Abstract
 

  
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.
Cherner M, Masliah E, Ellis RJ,et al.
Neurology 2002 Nov 26;59(10):1563-7
 Abstract
 
A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.
Clifford DB, McArthur JC, Schifitto G, et al
Neurology 2002 Nov 26;59(10):1568-73
 Abstract
 
Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the
NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study.
Starace F, Bartoli L, Aloisi MS, et al
Acta Psychiatr Scand 2002 Jul;106(1):20-6
 Abstract
 
  Relationships between cognition and structural neuroimaging findings in adults with human i
mmunodeficiency virus type-1.
Paul R, Cohen R, Navia B, Tashima K.
Neurosci Biobehav Rev 2002 May;26(3):353-9
 Abstract
 
  Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment.
Marder K, Albert SM, McDermott MP, et al.
Neurology 2003 May 13;60(9):1467-1473
 Abstract
 
  Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.
De Ronchi D, Faranca I, Berardi D, et al.
Arch Neurol 2002 May;59(5):812-8
 Abstract
 
  HIV-associated cognitive impairment before and after the advent of combination
therapy.
Sacktor N, McDermott MP, Marder K, et al.
J Neurovirol 2002 Apr;8(2):136-42
 Abstract

          Conference Reports, Abstracts, and Posters

 
Prevalence and risk factors for HIV associated neurocognitive disorders (HAND), 1996 to 2010:
results from an observational cohort
P. Balestra, V. Tozzi, M. Zaccarelli,  et al
(6th IAS Conference
 Abstracts

POSTER
HAART-experienced Subjects with HIV-associated Neurocognitive Disorders Have Longitudinally
Persistent Elevated HIV DNA Levels in CD14+CD16+ Monocytes
B Shiramizu, A Marshall, M Agsalda, et al
(17CROI )
PDF Poster    Abstract
 

POSTER
Predicting HIV-related Neurocognitive Dysfunction: The Relevance of Clinical Factors
J Muñoz-Moreno, N Pérez-Álvarez, S Letendre, et al
17CROI )
 PDF Poster    Abstract

POSTER
 APOE e4 and MBL2 O/O Genotypes Are Associated with Neurocognitive Impairment in HIV-infected
Former Plasma Donors from Anhui Province, China
St Spector, K Singh, S Gupta. et al
(17CROI )
PDF Poster    Abstract

POSTER
Neurocognitive Impairment and HIV Infection in Nigeria: Functional and Virologic Correlates
W Royal, A Akomolafe, A Habib,  et al
(17CROI )
 PDF Poster    Abstract
 
POSTER
Utility of Diagnostic Tools for HIV-associated Cognitive Impairment and Peripheral Neuropathy
in Western Kenya: Pilot Testing
J Kwasa, D Cettomai, E Lwanya, et al
(17CROI )
 PDF Poster    Abstract
 
POSTER
Impact of ApoE and Cerebrovascular Risk Factors on Brain Structure and Cognition in HIV in the
HAART Era
 Nakamoto, N Jahanshad, K Kallianpur, et al 
(17CROI )
 PDF Poster    Abstract

CVD and CVD Risk Factors Are Associated with Lower Baseline Neurocognitive Performance in the
SMART Neurology Substudy
E Wright, B Grund K Robertson, et al
(17CROI )
 Abstract
 
Neurocognitive Performance during Primary HIV-1 Infection
J Peterson, E Le, F Hecht, et al
(17CROI )
 Abstract

CEP-1347 as an Adjunctive Therapy for HIV-associated Cognitive Impairment
D Egger,t S Gorantla, H Dou, et al
(15 CROI )
 Abstract

Adverse Effect of ddI, ddC and d4T as a Component of  HAART on Cognitive Function
during HIV Infection
I Husstedt, B Hudelmeier, U Oelker-Gruneberg, et al
(15 CROI )
Abstract
 
A Phase II, Placebo-controlled, Double-blind Study of the Selegiline Transdermal System in the
Treatment of HIV-associated Cognitive Impairment
G Schifitto, N Sacktor, J Zhang, et al 
(13 CROI )
 Abstract
 
POSTER
Improved Cognitive Function in Immune Reconstituted Advanced AIDS Patients Is
Associated with Maintenance of HIV Suppression
A McCutchan. J Wu, P Williams, et al
 (11 CROI)
 PDF Poster    Abstract
 
POSTER
 Neuroocognitive Impairment and Survival in HIV-Positive Patients Treated with HAART:
Results from an Urban Observational Cohort
V Tozzi, P Balestra, D Serraino, et al
 (11 CROI)
 PDF Poster    Abstract
 
Encephalopathy
       
           Journal Papers, Abstracts, and Commentaries
 
 
Image evaluation of HIV encephalopathy: a multimodal approach using quantitative MR techniques.
Prado PT, Escorsi-Rosset S, Cervi MC, Santos AC.
Neuroradiology. 2011 May 17.
 Abstract

Posterior reversible encephalopathy related to tacrolimus in a liver transplanted HIV patient.
Courand PY, Christin F, Ben Cheikh A, et al
 Gastroenterol Clin Biol. 2009 Sep 23
 Abstract

Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection.
Douvoyiannis M, Litman N.
Int J Infect Dis. 2009 Mar 24.
Abstract
 
Clinical features and courses of 5 cases with HIV encephalopathy
Hashimoto R, Mukai E, Yokomaku Y, et al 
Rinsho Shinkeigaku. 2008 Mar;48(3):173-8.
Abstract
 
A patient with HIV encephalopathy presenting with parkinsonism during HAART therapy
Shimohata T, Takadou Y, Terajima K, et al 
No To Shinkei. 2006 Jun;58(6):495-9.
 Abstract
 
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune
restoration in AIDS-related progressive multifocal leukoencephalopathy.
 Vendrely A, Bienvenu B, Gasnault J, et al
Acta Neuropathol (Berl). 2005 Mar 1;
Abstract

HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy
in the era of highly active antiretroviral therapy.
Neuenburg JK, Brodt HR, Herndier BG, et al.  
J Acquir Immune Defic Syndr 2002 Oct 1;31(2):171-7
 Abstract

 

          Conference Reports, Abstracts, and Posters

  POSTER
 Potentially Preventive Effect of Didanosine against HIV Encephalopathy
I Poizot Martin, M P Milon, M P Drogoul, et al  1
(11 CROI)
PDF Poster    Abstract  
Encephalitis
       
           Journal Papers, Abstracts, and Commentaries
 
 
HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
Bingham R, Ahmed N, Rangi P, et al
Int J STD AIDS. 2011 Oct;22(10):608-9.
Abstract

Dyad of CD40/CD40 Ligand Fosters Neuroinflammation at the Blood-Brain Barrier
and Is Regulated via JNK Signaling: Implications for HIV-1 Encephalitis.
Ramirez SH, Fan S, Dykstra H, et al
J Neurosci. 2010 Jul 14;30(28):9454-64.
 Abstract

Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a
multiple sclerosis-like illness.
Berger JR, Fee DB, Nelson P, Nuovo G.
 J Neurovirol. 2009 May 14:1-6.
Abstract
 

FULL-TEXT ARTICLE
Fatal HIV Encephalitis in HIV-Seronegative Patients.
Martin TM, Rich JD.
Emerg Infect Dis. 2009 Jan;15(1):129-31
 Letter
 
Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients:
clinical description and follow-up.
Villar Del Saz S, Sued O,  et al
 J Neurovirol. 2008 Nov 26:1-6.
Abstract
 
Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium
subjects with HIV encephalitis.
Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM.
J Neuroimmune Pharmacol. 2006 Dec;1(4):410-20.
Abstract
 
Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy.]
Trocello JM, Blanchet A, Bourdain F, et al  
Rev Neurol (Paris). 2006 Jan;162(1):89-91
 Abstract
 
The shifting patterns of HIV encephalitis neuropathology.
Everall IP, Hansen LA, Masliah E.
Neurotox Res. 2005 Oct;8(1,2):51-62.
 Abstract
 
Subacute uveomeningoencephalitis as the presenting symptom of acute infection by
the human immunodeficiency virus.
Pascual-Lozano AM, Salvador-Aliaga A, Coret-Ferrer F, Lainez-Andres JM.
Rev Neurol. 2005 Sep 1-15;41(5):273-6.
 Abstract
 
Severe HIV-1 Encephalitis and Development of Cerebral Non-Hodgkin Lymphoma in a Patient
with Persistent Strong HIV-1 Replication in the Brain despite Potent HAART - Case Report and
Review of the Literature.
 Baeuerle M, Schmitt-Haendle M, et al 
Eur J Med Res. 2005 Jul 29;10(7):309-16.
 Abstract

HIV encephalitis simulating Huntington's disease.
Sevigny JJ, Chin SS, Milewski Y, et al
Mov Disord. 2005 Feb 9;
Abstract

 

          Conference Reports, Abstracts, and Posters

  Cytomegalovirus (CMV) encephalitis in a patient with advanced HIV after initiation of
highly active antiretroviral therapy (HAART)
 W Tantisiriwat, C Ruangkit, S Reepolmaha, et al
 (15IAC)
 Abstract
Cerebral Histoplasmosis    
Histoplasmosis      

        Journal Papers, Abstracts, and Commentaries  

  A case of HIV-associated cerebral histoplasmosis successfully treated with
fluconazole.
Knapp S, Turnherr M, Dekan G, Willinger B , et al.  
Eur J Clin Microbiol Infect Dis 1999 Sep;18(9):658-61
Abstract
Cerebral Toxoplasmosis        
Toxoplasmosis        

          Journal Papers, Abstracts, and Commentaries

 
Cerebral toxoplasmosis in a patient with acquired immunodeficiency syndrome.
Naqi R, Azeemuddin M, Ahsan H.
J Pak Med Assoc. 2010 Apr;60(4):316-8.|
 Abstract

Frequent hemorrhagic lesions in cerebral toxoplasmosis in AIDS patients.
Bhagavati S, Choi J.
 J Neuroimaging. 2009 Apr;19(2):169-73.
 Abstract

Severe Toxoplasma gondii I/III recombinant genotype encephalitis in a HIV patient.
Genot S, Franck J, Forel JM, et al  
J Clin Microbiol. 2007 Jul 18;
Abstract

 HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis
in a 45-year-old man.
Murata M, Furusyo N, Otaguro S,
J Infect Chemother. 2007 Feb;13(1):51-5
 Abstract
 
Cerebral Toxoplasmosis in HIV-Positive Patients in Brazil: Clinical Features and Predictors
of Treatment Response in the HAART Era.
Vidal JE, Hernandez AV, Oliveira AC, Dauar RF, et al
AIDS Patient Care STDS. 2005 Oct;19(10):840-8.
Abstract
 
Drug monitoring of pyrimethamine during maintenance therapy of toxoplasmic
encephalitis in patients with advanced HIV infection during HAART.
Langmann P, Schirmer D, Zilly M, Klinker H.  
Med Sci Monit. 2004 May;10(5):PI65-9.
Abstract

Cerebral Toxoplasmosis.
Nath A, Sinai AP.
Curr Treat Options Neurol 2003 Jan;5(1):3-12
 Abstract
   
  Host resistance in the brain against Toxoplasma gondii.
Suzuki Y.
J  Infect Dis 2002 Feb 15;185 Suppl 1:S58-65
Abstract
   
  Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium
complex infection and toxoplasmic encephalitis.
Zeller V, Truffot C, Agher R, et al.
Clin Infect Dis 2002 Mar 1;34(5):662-7
Abstract
   
  Case report. Toxoplasma encephalitis after initiation of HAART.
Tsambiras PE, Larkin JA, Houston SH.
AIDS Read 2001 Dec;11(12):608-10, 615-6
 Abstract
   
  Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment
of toxoplasmic encephalitis in AIDS.
Jacobson JM, Hafner R, Remington J, et al.
AIDS 2001 Mar 30;15(5):583-9
 Abstract
   
  HIV-2 infection with cerebral toxoplasmosis and lymphomatoid granulomatosis.
Issakhanian M, Chang L, Cornford M et al.
J Neuroimaging 2001 Apr;11(2):212-6
 Abstract
   
  Cerebral toxoplasmosis in HIV- infected patients intolerant of cotrimoxazole.
Rabaud C, May T, Beuscart C, Reynes J, et al.
Ann Med Interne (Paris) 1998 Mar;149(2):62-6
 Abstract
   
  Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii
pneumonia  relapse and toxoplasmic encephalitis in patients with AIDS.
Schurmann D, Bergmann F, Albrecht H, et al.
J Infect 2001 Jan;42(1):8-15
 Abstract
   
  Central Nervous System Toxoplasmosis in HIV Pathogenesis, Diagnosis, and Therapy.
Luft BJ, Chua A.
Curr Infect Dis Rep 2000 Aug;2(4):358-362
 Abstract
Cerebral Lymphocytosis
       

        Journal Papers, Abstracts, and Commentaries  
  Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration
induced by HAART.
Miller RF, Isaacson PG, Hall-Craggs M,et al.  
Acta Neuropathol (Berl). 2004 Apr 14
 Abstract
Leukoencephalopathy
Progressive Multifocal Leukoencephalopathy      

        Journal Papers, Abstracts, and Commentaries  
 
Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count:
the use of magnetic resonance imaging plus spectrometry studies.
Manfredi R, Piergentili B, Marinacci G, Calza L.
 Int J STD AIDS. 2012 Mar;23(3):e35-
 Abstract

Leucoencephalopathy in a patient with type I human immunodeficiency virus (HIV-1) infection
and symptoms of a hypertensive emergency
 García-Blázquez V, Vicente-Bártulos A, Lourido-García D, Dronda F
 Enferm Infecc Microbiol Clin. 2011 Nov 25..
 Abstract

Acute transient inflammatory leukoencephalopathy in HIV.
Tavazzi E, Magrassi L, Maccabruni A,  et al
Neurol Sci. 2011 Jan 14
 Abstract

Reversible Posterior Leukoencephalopathy Syndrome in 2 HIV-Infected Patients Receiving
Antiretroviral Therapy.
Ridolfo AL, Resta F, Milazzo L, et al 
Clin Infect Dis. 2008 Jan 15;46(2):e19-22.
 Abstract

Convalescence of atypical reversible posterior leukoencephalopathy syndrome
in human immunodeficiency virus infection.
Tanioka R, Yamamoto Y, Sakai M, et al 
J Med Invest. 2007 Feb;54(1-2):191-4
 Abstract
Memory Disorders
       

        Journal Papers, Abstracts, and Commentaries  
 
Is prospective memory a dissociable cognitive function in HIV infection?
Gupta S, Paul Woods S, Weber E,  et al
 J Clin Exp Neuropsychol. 2010 Apr 27:1-11
 Abstract

Frequency and predictors of self-reported prospective memory complaints in individuals
infected with HIV.
Woods SP, Carey CL, Moran LM 
Arch Clin Neuropsychol. 2007 Feb 5
 Abstract

Prospective memory in HIV-1 infection.
Carey CL, Woods SP, Rippeth JD, Heaton RK
J Clin Exp Neuropsychol. 2006 May;28(4):536-48.
 Abstract
 
Memory loss in persons with HIV/AIDS: assessment and strategies for coping.
Selnes OA.
AIDS Read. 2005 Jun;15(6):289-92, 294
 Abstract
Movement/Motor Disorders
       
           Journal Papers, Abstracts, and Commentaries
 
 
Upper and Lower Limb Motor Impairments in Alcoholism, HIV Infection, and Their Comorbidity.
Fama R, Eisen JC, Rosenbloom MJ, Sassoon SA, et al
Alcohol Clin Exp Res. 2007 Mar 31;
 Abstract

Human Immunodeficiency Virus 1-associated Minor Motor Disorders:Perfusion-
weighted MR Imaging and H MR Spectroscopy.
Wenserski F, Von Giesen HJ
Radiology 2003 May 20
 Abstract

  
     
  Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction.
Clay PG, Adams MM.
Ann Pharmacother 2003 Feb;37(2):202-5
 Abstract		  
     
  Movement disorders in 28 HIV-infected patients.
Mattos JP, Rosso AL, Correa RB, Novis SA.
Arq Neuropsiquiatr 2002 Sep;60(3-A):525-30
 Abstract		  
     
  HIV-related movement disorders: epidemiology, pathogenesis and management.
Cardoso F.
CNS Drugs 2002;16(10):663-8
 Abstract		  
     
  Parkinsonism in HIV dementia.
Koutsilieri E, Sopper S, Scheller C, et al
J Neural Transm 2002 May;109(5-6):767-75
 Abstract		  
     
  Potential time course of human immunodeficiency virus type 1-associated minor motor
deficits: electrophysiologic and positron emission tomography findings.
von Giesen HJ, Antke C, Hefter H, et al
Arch Neurol 2000 Nov;57(11):1601-7
 Abstract		  
     
  Hemichorea-hemiballism associated to cryptococcal granuloma in a patient with AIDS:
case report
Teive HA, Troiano AR, Cabral NL, et al
Arq Neuropsiquiatr 2000 Sep;58(3B):965-8
 Abstract		  

          Conference Reports, Abstracts, and Posters

  POSTER
High Prevalence of Locomotor Disorder in HIV-infected Patients, ANRS CO3
Aquitaine Cohort, 2007 to 2009
L Richert, F Bonnet, P Mercié, et al
(17CROI )
 PDF Poster    Abstract
Perception Disorders
 

           Journal Papers, Abstracts, and Commentaries

  Perceptual span deficits in adults with HIV.
Hardy DJ, Castellon SA, Hinkin CH.
 J Int Neuropsychol Soc. 2004 Jan;10(1):135-40.
Abstract
Seizures/Epilepsy
       

     Journal Papers, Abstracts, and Commentaries
 
 
Epilepsy: Issues with antiepileptic drug use in HIV-infected patients.
 Brew BJ, Thompson J.
Nat Rev Neurol. 2012 Mar 13. doi: 10.1038.
 Abstract

Sodium valproate and highly active antiretroviral therapy in HIV positive patients who
develop new onset seizures.
Yacoob Y, Bhigjee AI, Moodley P, Parboosing R.
Seizure. 2010 Oct 15.
 Abstract

Seizures in HIV-seropositive individuals: NIMHANS experience and review.
 Satishchandra P, Sinha S.
Epilepsia. 2008 Aug;49 Suppl
Abstract
 

Comorbid HIV Encephalopathy and Cocaine Use as a Risk Factor for New-onset Seizure
Disorders.
Kenedi CA, Joynt KE, Goforth HW.
CNS Spectr. 2008 Mar;13(3):230-4.
 Abstract
 
Frequency of seizures and epilepsy in neurological HIV-infected patients.
Kellinghaus C, Engbring C, Kovac S, et al 
Seizure. 2007 Jul 5;
 Abstract
 
Special Populations: The Management of Seizures in HIV-positive Patients.
Mullin P, Green G, Bakshi R.
Curr Neurol Neurosci Rep. 2004 Jul;4(4):308-14.
 Abstract

CNS Main Page Main New/Newsworthy  Home Page

HIV-Associated Brain Disorders